191 related articles for article (PubMed ID: 35878532)
1. Overexpression of SFXN1 indicates poor prognosis and promotes tumor progression in lung adenocarcinoma.
Chen L; Kang Y; Jiang Y; You J; Huang C; Xu X; Chen F
Pathol Res Pract; 2022 Sep; 237():154031. PubMed ID: 35878532
[TBL] [Abstract][Full Text] [Related]
2. SFXN1-mediated immune cell infiltration and tumorigenesis in lung adenocarcinoma: A potential therapeutic target.
Li Y; Yang W; Liu C; Zhou S; Liu X; Zhang T; Wu L; Li X; Zhang J; Chang E
Int Immunopharmacol; 2024 May; 132():111918. PubMed ID: 38537539
[TBL] [Abstract][Full Text] [Related]
3. SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with
Zhang YH; Liu XS; Gao Y; Yuan LL; Huang ZM; Zhang Y; Liu ZY; Yang Y; Liu XY; Ke CB; Pei ZJ
Lung Cancer; 2024 Feb; 188():107449. PubMed ID: 38184958
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma.
Liu W; Du Q; Mei T; Wang J; Huang D; Qin T
BMC Cancer; 2024 Jan; 24(1):94. PubMed ID: 38233752
[TBL] [Abstract][Full Text] [Related]
5. Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway.
Chen X; Zhang W; Xu X
World J Surg Oncol; 2021 Aug; 19(1):232. PubMed ID: 34362378
[TBL] [Abstract][Full Text] [Related]
6. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway.
Zhang H; Cao Y; Tang J; Wang R
Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221
[TBL] [Abstract][Full Text] [Related]
7. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
8. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
[TBL] [Abstract][Full Text] [Related]
9. FHL2 promotes the aggressiveness of lung adenocarcinoma by inhibiting autophagy via activation of the PI3K/AKT/mTOR pathway.
Wang S; Liu B; Su Y; Wang N; Dong P; Xu X; Huang L; Li S; Gu J; Qiu Y; Deng J; Lin Z; Zhou Y
Thorac Cancer; 2024 Mar; 15(8):630-641. PubMed ID: 38323374
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of CENPM facilitates lung adenocarcinoma progression via PI3K/AKT/mTOR signaling pathway.
Liu C; Wang Y; Dao Y; Wang S; Hou F; Yang Z; Liu P; Lv J; Lv L; Li G; Zhou Y; Deng Z
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(1):99-112. PubMed ID: 35130633
[TBL] [Abstract][Full Text] [Related]
11. [S100A10 promotes proliferation and invasion of lung adenocarcinoma cells by activating the Akt-mTOR signaling pathway].
Wang H; Sun Z; Zhao W; Geng B
Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):733-740. PubMed ID: 37313814
[TBL] [Abstract][Full Text] [Related]
12. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
Ma G; Yang L; Dong J; Zhang L
Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
[TBL] [Abstract][Full Text] [Related]
13. UHMK1 promotes lung adenocarcinoma oncogenesis by regulating the PI3K/AKT/mTOR signaling pathway.
Li Y; Wang S; Jin K; Jin W; Si L; Zhang H; Tian H
Thorac Cancer; 2023 Apr; 14(12):1077-1088. PubMed ID: 36919755
[TBL] [Abstract][Full Text] [Related]
14. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway.
Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M
Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
17. DNA repair/recombination protein 54L promotes the progression of lung adenocarcinoma by activating mTORC1 pathway.
Liu C; Ren W; Zhang Z; Guan J
Hum Cell; 2023 Jan; 36(1):421-433. PubMed ID: 36454390
[TBL] [Abstract][Full Text] [Related]
18. SLITRK6 promotes the progression of lung adenocarcinoma by regulating PI3K/AKT/mTOR signaling and Warburg effect.
Yu F; Zhao X; Li M; Meng M
Apoptosis; 2023 Aug; 28(7-8):1216-1225. PubMed ID: 37219677
[TBL] [Abstract][Full Text] [Related]
19. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
20. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway.
Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
